Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,527 across all filing types
Latest filing 2016-03-29 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
2015年年度报告
Annual Report Classification · 100% confidence The document is titled "华兰生物工程股份有限公司 2015 年年度报告全文" which translates to "Hualan Biological Engineering Co., Ltd. 2015 Annual Report Full Text." It contains detailed sections typical of an annual report, including company overview, financial data for the year 2015, management discussion and analysis, business overview, financial indicators, and governance information. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes audited financial figures, management statements, and detailed business descriptions. There is no indication that this is merely an announcement of a report or a certification letter. Therefore, this document fits the definition of an Annual Report (10-K). FY 2015
2016-03-29 Chinese
2015年度社会责任报告书
Environmental & Social Information Classification · 95% confidence The document is titled as the "2015 Annual Social Responsibility Report" of 华兰生物工程股份有限公司. It details the company's activities and performance related to social responsibility, including environmental protection, employee welfare, shareholder rights, and community engagement for the year 2015. The content focuses on Environmental, Social, and Governance (ESG) factors and sustainability efforts rather than financial results or corporate governance structure alone. The length of the document (8006 characters) and the detailed narrative confirm it is a full report rather than a brief announcement. Therefore, the document fits the category of Environmental & Social Information (SR).
2016-03-29 Chinese
2015年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year 2015 by 华兰生物工程股份有限公司. It discusses the evaluation of the company's internal control effectiveness as of December 31, 2015, including financial and non-financial internal control deficiencies, governance structure, risk management, and compliance with regulatory requirements. The content is detailed and specific to internal control evaluation rather than a full annual report or audit report. It does not present full financial statements or comprehensive financial performance data typical of an Annual Report (10-K) or Interim Report (IR). It is also not a simple announcement or certification but a substantive report on internal control evaluation. This matches the description of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluation results. Therefore, the document should be classified as AR with high confidence. FY 2015
2016-03-29 Chinese
2015年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2015 年度业绩快报' which translates to '2015 Annual Performance Express Report' or '2015 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2015, including revenue, profit, net assets, and earnings per share. The document explicitly states that the data is preliminary, internally audited but not yet audited by an accounting firm, and may differ from the final annual report. The length is 1615 characters, which is quite short and typical for an earnings release or earnings quick report rather than a full annual report. There is no indication that this is a full annual report (10-K) or a detailed management discussion and analysis (MDA). It is not a report publication announcement since it contains actual financial data, not just a notice. The document is a preliminary earnings release (业绩快报) which aligns with the Earnings Release (ER) category, as it provides key highlights of the financial results for the year but is not a comprehensive report. FY 2015
2016-02-28 Chinese
关于公司股东股票质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge of shares by a significant shareholder (holding more than 5% of shares) of the company. It details the number of shares pledged, the pledge date, the pledgee, and the proportion of shares pledged relative to total holdings and total share capital. There is no financial report, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, as it informs about changes in significant share ownership levels or related share transactions such as pledges. Therefore, the appropriate classification is 'MRQ' (Major Shareholding Notification). The document length and content confirm it is not a report or announcement of a report but a regulatory announcement about share pledging.
2016-01-21 Chinese
关于全资子公司取得单采血浆许可证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the acquisition of a license by a wholly-owned subsidiary of the company. It does not contain financial data, management discussion, or detailed report content. It is an official notice about a regulatory or operational update rather than a financial report or meeting material. The document length is only 409 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-01-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.